(Q26770830)

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Development of the 25-item National Eye Institute Visual Function Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

A SELF-RATING DEPRESSION SCALE

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Asse

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Impaired functional status in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Androgen control of gene expression in the rabbit meibomian gland.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Dry eye: diagnosis and current treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Conventional therapy of Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Impact of dry eye syndrome on vision-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The impact of dry eye disease on visual performance while driving

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Prevalence of dry eye syndrome among US women

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

A Rating Instrument For Anxiety Disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Utility assessment among patients with dry eye disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Performance and repeatability of the NEI-VFQ-25 in patients with dry eye

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The economic burden of dry eye: a conceptual framework and preliminary assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The economic burden of dry eye disease in the United States: a decision tree analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Tear film osmolarity measurements in dry eye disease using electrical impedance technology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Clinically important difference in dry eye: change in IDEEL-symptom bother.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Prevalence of dry eye syndrome in an adult population

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

UK patients with primary Sjögren's syndrome are at increased risk from clinical depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

The international workshop on meibomian gland dysfunction: introduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Association between depression and dry eye disease in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Differential diagnosis of dry eye conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Work productivity loss in patients with dry eye disease: an online survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Impact of dry eye on work productivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Annual direct cost of dry eye in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021

Etiology, prevalence, and treatment of dry eye disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JTOS.2015.11.002

7 January 2021